Literature DB >> 24256362

Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.

Andrew J Percy1, Carol E Parker, Christoph H Borchers.   

Abstract

Quantitative plasma proteomics, through the use of targeted MRM-MS and isotopically labeled standards, is emerging as a popular technique to address biological- and biomedical-centered queries. High precision and accuracy are essential in such measurements, particularly in protein biomarker research where translation to the clinic is sought. Standardized procedures and routine performance evaluation of all stages of the workflow (both pre-analytical and analytical) are therefore imperative to satisfy these requisites and enable high inter-laboratory reproducibility and transferability. In this review, we first discuss the pre-analytical and analytical variables that can affect the precision and accuracy of 'absolute' quantitative plasma proteomic measurements. Proposed strategies to limit such variability will then be highlighted and unmet needs for future exploration will be noted. Although there is no way to conduct a truly comprehensive review on this broad, rapidly changing topic, we have highlighted key aspects and included references to review articles on various sub-topics.

Mesh:

Substances:

Year:  2013        PMID: 24256362     DOI: 10.4155/bio.13.245

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  5 in total

Review 1.  Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

Authors:  Carol E Parker; Christoph H Borchers
Journal:  Mol Oncol       Date:  2014-03-20       Impact factor: 6.603

2.  Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.

Authors:  Yung-Chin Hsiao; Lang-Ming Chi; Kun-Yi Chien; Wei-Fan Chiang; Szu-Fan Chen; Yao-Ning Chuang; Shih-Yu Lin; Chia-Chun Wu; Ya-Ting Chang; Lichieh Julie Chu; Yi-Ting Chen; Shu-Li Chia; Chih-Yen Chien; Kai-Ping Chang; Yu-Sun Chang; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2017-08-18       Impact factor: 5.911

3.  Degradation and Stabilization of Peptide Hormones in Human Blood Specimens.

Authors:  Jizu Yi; David Warunek; David Craft
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

4.  Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.

Authors:  Maria Frantzi; Akshay Bhat; Agnieszka Latosinska
Journal:  Clin Transl Med       Date:  2014-03-29

Review 5.  Proteomic Applications in the Study of Human Mesenchymal Stem Cells.

Authors:  Jesús Mateos; Pablo Fernández Pernas; Juan Fafián Labora; Francisco Blanco; María Del Carmen Arufe
Journal:  Proteomes       Date:  2014-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.